Results 101 to 110 of about 845 (152)

Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. [PDF]

EMBO Mol Med
Wu J, Kakhlon O, Weil M, Lossos A, Minassian BA.   +4 more
europepmc   +1 more source

Dapagliflozin ameliorates Lafora disease phenotype in a zebrafish model.

Biomed Pharmacother
Della Vecchia S, Imbrici P, Liantonio A, Naef V, Damiani D, Licitra R, Bernardi S, Marchese M, Santorelli FM.   +8 more
europepmc   +1 more source

Lafora Bodies Associated with Neurologic Signs in a Cat [PDF]

Veterinary Pathology, 1998
Lafora bodies (polyglucosan deposits) were identified in the brain of a young adult cat with neurologic signs characterized by intermittent but progressively worsening head and body tremors. The cerebellar cortex was the most severely affected area of brain, and the deposits were identified within Purkinje cell bodies and processes and throughout the ...
W L Steffens
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

An unusual case of Lafora body disease

European Journal of Neurology, 1999
A case is described in which non‐convulsive status epilepticus (NCSE) prompted further investigation leading to the diagnosis of Lafora body disease (LBD). The onset of NCSE was temporally related to the withdrawal of sodium valproate and introduction of carbamazepine, which may have been precipitating factors.
R G, Corkill, R J, Hardie
openaire   +2 more sources